Drawing for RYAPT

USPTO serial 79191842

RYAPT

Reviewed by CopyMark Law Group

Reg. 5126584Status 404
Filing date
Status date
Registration date
Jan 24, 2017
Examiner
STIGLITZ, SUSAN R
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RYAPT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthmaSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 9, 2020DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Mar 9, 2020DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 24, 2017GPNXNOTIFICATION PROCESSED BY IB—
Mar 8, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 8, 2017FIMPFINAL DISPOSITION PROCESSED—
Feb 23, 2017GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Jan 24, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 8, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 19, 2016NPUBNOTICE OF PUBLICATION—
Sep 27, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 27, 2016DOCKASSIGNED TO EXAMINER—
Sep 24, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 20, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 16, 2016LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 15, 2016SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance